Abstract

CASE REPORT ON RISPERIDONE INDUCED HYPERPROLACTINEMIA ON SHORT-TERM USE

Josna James*, Geethu C., Elizabeth Phoeba Paul, Jasmin Elizabeth Thomas, Hemalatha S. and Sivakumar T.

Abstract

Risperidone, atypical antipsychotic widely used for the treatment of schizophrenia has high potential to induce hyperprolactinemia. The effect may be symptomatic or asymptomatic. Here, a patient with hyperprolactinemia has been reported with no symptoms of the adverse effect. Initially the patient had normal prolactin level, when the dose was increased due to ineffectiveness of the drug simultaneously prolactin level also raised which was determined through routine lab investigation. The drug was stopped immediately and switched over to Olanzapine 10mg/day. The other choice of treatment is to add dopamine agonist or Aripiprazole to attenuate the effect.

Keywords: Risperidone, atypical antipsychotic, Aripiprazole.